Clear Street’s CERo Therapeutics Warrants CEROW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-461,653
| Closed | -$6.14K | – | 1007 |
|
|
2025
Q3 | $6.14K | Buy |
461,653
+267,829
| +138% | +$4.77K | ﹤0.01% | 716 |
|
|
2025
Q2 | $4.61K | Buy |
193,824
+49,399
| +34% | +$766 | ﹤0.01% | 556 |
|
|
2025
Q1 | $2.09K | Sell |
144,425
-800
| -0.6% | -$11 | ﹤0.01% | 464 |
|
|
2024
Q4 | $1.21K | Hold |
145,225
| – | – | ﹤0.01% | 483 |
|
|
2024
Q3 | $741 | Buy |
145,225
+100
| +0.1% | +$2 | ﹤0.01% | 613 |
|
|
2024
Q2 | $2.92K | Buy |
145,125
+1,200
| +0.8% | +$70 | ﹤0.01% | 558 |
|
|
2024
Q1 | $9.82K | Buy |
143,925
+2,883
| +2% | +$175 | ﹤0.01% | 424 |
|
|
2023
Q4 | $3.31K | Buy |
141,042
+51,355
| +57% | +$1.6K | ﹤0.01% | 496 |
|
|
2023
Q3 | $6.42K | Hold |
89,687
| – | – | ﹤0.01% | 623 |
|
|
2023
Q2 | $5.48K | Buy |
89,687
+2,031
| +2% | +$88 | ﹤0.01% | 800 |
|
|
2023
Q1 | $3.52K | Sell |
87,656
-267,529
| -75% | -$12.1K | ﹤0.01% | 748 |
|
|
2022
Q4 | $15K | Buy |
355,185
+16,467
| +5% | +$866 | ﹤0.01% | 437 |
|
|
2022
Q3 | $27K | Buy |
338,718
+5,600
| +2% | +$472 | ﹤0.01% | 424 |
|
|
2022
Q2 | $33K | Buy |
+333,118
| New | +$53.7K | ﹤0.01% | 315 |
|
|
2022
Q1 | – | Sell |
-5,797
| Closed | -$2K | – | 481 |
|
|
2021
Q4 | $2K | Buy |
+5,797
| New | +$2.67K | ﹤0.01% | 251 |
|
Other funds holding CEROW
Clear Street's CEROW Position: Q4 2025 in Review
Clear Street sold out of CERo Therapeutics Warrants (CEROW) in Q4 2025, closing a stake of 461,653 shares — an estimated $6.14K sold.
Clear Street first reported a position in CEROW in Q4 2021 and held it in 15 quarters. The position peaked at $33K in Q2 2022. 1 fund tracked by Wall St. Rank holds CEROW as of Q4 2025.
- Clear Street reported no remaining CERo Therapeutics Warrants position as of Q4 2025 after selling out during the quarter.
- Clear Street sold 461,653 CERo Therapeutics Warrants shares in Q4 2025, an estimated $6.14K.
- Clear Street first reported a position in CERo Therapeutics Warrants in Q4 2021 and held it in 15 quarters.
- Clear Street's CERo Therapeutics Warrants position peaked at $33K in Q2 2022.
- 1 fund tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2025.
Based on Clear Street's 13F filing for Q4 2025, filed 13 Feb 2026.